News

U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices ...
While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston Scientific told customers that its Endotak Reliance defibrillation leads with ...
The FDA recently said there is no reason to restrict the use of certain PFAS in medical devices, citing decades of safe use and no evidence linking the materials to patient harm.
For now, FDA has determined that it will not seek to impose a blanket PFAS restriction for medical device applications, as ...
Boston Scientific has updated the instructions for use for products deployed in the implantation of its Watchman heart device ...
The FDA has issued an early communication to warn of updated instructions for use for certain Boston Scientific Watchman access systems.
The FDA said some of Boston Scientific ’s Endotak Reliance defibrillator wires can become calcified, which may stop the ...
Boston Scientific is recommending updates to the instructions for use to minimize the issue, which has been tied to 17 deaths ...
The agency’s decision was based on the outcomes of the double-blind, randomised, sham-controlled RESET-RA study.
The FDA hasn’t released official numbers on the terminations, but former FDA officials have pegged the number at roughly 700, with more than 220 coming from the medical device center.
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
The "FDA Medical Device Regulation" directory has been added to ResearchAndMarkets.com's offering. The Guide to Medical Device Regulation contains the highest quality analyses on the regulation of ...